NiraWave™ C

The trusted optical imaging agent

Order no:

NiraWave™ C optical imaging agent (1 x 5 injections): 130 - 095 - 154
NiraWave™ C optical imaging agent (5 x 5 injections): 130 - 095 - 155

price per item:
€260.00
Excluding VAT and shipping costs

NiraWave C is formulated from the clinically proven indocyanine green (ICG) agent for use in small animal imaging. It is a versatile dye that has been used for angiography of the eye, organ perfusion, rheumatology diagnostics, and photodynamic therapy research.

NiraWave C, the trusted standard from clinical practice:

  • Saves you the time by eliminating tedious dilution and formulation steps
  • Provides consistently reliable results
  • Serves as a reference contrast agent
  • Is hassle-free allowing you to focus on the experiment at hand
  • Nira Wave C is Viscover’s tried and tested indocyanine green for optical imaging in animals
  • Indocyanine green has been clinically used for various applications: angiography in opthalmology, organ perfusion, as well as rheumatology diagnostics based on vascular leakage
Physico-chemical properties and structure
Molecular weight:

775 g mol -1

Emission wavelength:

820 nm

Excitation wavelength:

650 - 780 nm

Structural formula of indocyanine green



Normalized absorption and emission spectra of NiraWave C in plasma

NiraWave™ C optical imaging of mouse ear vessels
Optical Imaging of blood vessels in the mouse ear obtained at 30 s post injection of NiraWave C.
Selected references
  1. Lao, W.W. et al. (2014) A new rat model for orthotopic abdominal wall allotransplantation. Plast Reconstr Surg Glob Open. 2(4): e136.
  2. Reynolds, J.S. et al. (1999) Imaging of spontaneous canine mammary tumors using fluorescent contrast agents. Photochem. Photobiol. 70: 87-94.
  3. Li, X. et al. (1995) Tumor localization using fluorescence of indocyanine green (ICG) in rat models. Proc. SPIE.
    2389: 789-797.
  4. Baeumler, W. et al. (1999) Photo-oxidative killing of human colonic cancer cells using indocyanine green and infrared light. Br. J. Cancer. 80: 360-363.
Further information